COVID-19 cases from May 2021-May 2022 in Georgia, US. by Ludy R. Carmola (20978107)

DM and CVD events and rates by period for COVID-19 cases and controls. by Emma Rezel-Potts (9159882)

Requirements for reporting C19ST results. by Melody Sakala (18176481)

Subjects:

Distribution of cases confirmed with SARS-CoV-2 infection over time. by Che Zhang (1522306)

Genotype distribution of SNPs in case and control groups. by Ruijuan Guan (671518)

Subjects:

Survival curves of confirmed cases of COVID-19 in nine provinces of Lima, Peru. by Wendy Nieto-Gutierrez (6029735)

Subjects:

Dispersion analysis of weekly COVID-19 case data for Jefferson County, Alabama. by Rachael Aber (21703264)

Subjects:

Case. by Ki Young Lee (3808507)

Map of last 28-day cases of Covid-19 03/10/2023. by C. A. Zuniga-Gonzalez (17409692)

Characteristics of cases by SARS-CoV-2 status. by David Goodman-Meza (4532713)

Average care task waiting time within a shift as COVID-19 positive (C+) patients increased from 1 to 5. by Sadeem Munawar Qureshi (8705436)

Subjects:

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Contribution of the Ag-RDT case-finding strategy to the diagnosis of COVID-19. by John Otokoye Otshudiema (15627474)

Subjects:

Summary of the care task groups programmed into the DES model and their task duration, priority rank, and sensitivity to COVID-19 where C+ = COVID+ patients; C- = non-COVID patient... by Sadeem Munawar Qureshi (8705436)

Subjects:

Average number of tasks missed when caring for one to five COVID-19 (C+) positive patients. by Sadeem Munawar Qureshi (8705436)

Subjects:

Cost for accessing C19 self-testing kits. by Melody Sakala (18176481)

Subjects:

Risk of severe COVID-19 by age group for increased risk patients not accessing antiviral treatment— Mass General Brigham, June to December 2022. by Scott Dryden-Peterson (227433)

Subjects:

Temporal distribution of COVID-19 cases in Curitiba (Brazil), hospital admissions, and viral genotype. by Natalia R. Domino (17604907)

Risk of severe COVID-19 by WHO risk groups for increased risk patients not accessing antiviral treatment— Mass General Brigham, June to December 2022. by Scott Dryden-Peterson (227433)

Subjects:

Risk of severe COVID-19 by NIH prioritization tier for increased risk patients not accessing antiviral treatment— Mass General Brigham, June to December 2022. by Scott Dryden-Peterson (227433)

Subjects: